About Us

Wendy Webber Nelson, PhD

President & Founder

Wendy Webber Nelson, PhD, is the President and Founder of the Boston Biotech Forum. Formerly named the Boston Cambridge Bioanalytical Discussion Group, the dinner meeting was initiated in 2011 to address pertinent industry topics with technical experts from many local biotechnology and pharmaceutical companies while also incorporating an element of networking. Participation is by invitation only, and each event is limited to 40-45 people to maintain an intimate and collaborative setting for presentation and discussion of relevant subjects. The distribution list includes over 500 professionals from over 280 local biotech and pharma companies, venture capital and consulting firms. Along with running the Boston Biotech Forum, Wendy currently works full-time at Danforth Advisors in a Corporate Development role, is a Business Advisor for Cytimmune Biosciences, and is a Venture Partner for Waterman Ventures. The Boston Biotech Forum has multiple sponsors, including ChemPartner, Fort Point PM, JP Morgan, Choate, Pacific Western Bank, Alexandria Real Estate, Alexandria Launch Labs, Diversified Search and Danforth Advisors. Wendy has over 23 years of business development, project management, operational, and R&D experience in biotechnology and large pharma companies, as well as in global CROs. Prior to assuming her positions at Danforth Advisors and Cytimmune, Wendy was CEO of LeadingBiotech, an organization that ran executive level conferences in the life science space around the US and in Europe. Prior to that, Wendy spent about 12 years in business development roles of increasing responsibility for various CROs, including Frontage Laboratories, inVentiv, Worldwide Clinical Trials and QPS. Prior to her roles in business development, Wendy was with Alantos Pharmaceuticals where she was responsible for Project Management and Operations of the two company programs and participated in many aspects of the post-merger integration following the $300M acquisition of Alantos by Amgen in 2007. She began her career in R&D at Alkermes, where she worked in formulation development.

Wendy (WL Webber) is an inventor on multiple patents and patent applications, and is the senior author of a number of scientific publications. Wendy served several years on the organizational committees for both the Progeria Research Foundation and MIT Enterprise Forum and is currently volunteering with LIT Conversations. She has also participated in the MassCONNECT mentoring program through MassBio. Dr. Nelson received her ScB and MS in Engineering and PhD in Medical Sciences all from Brown University.